Study of virus infections after pediatric transplants
Part of Blood & lymphatic, Immune system & allergy, Infections clinical trials.
This study looks at how respiratory viruses behave and how the body responds in children who are about to receive, or have recently received, a transplant. It may help doctors better diagnose and treat viral infections in transplant patients by studying blood samples and test results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old at the time of the planned transplant
- You are getting an allogeneic stem cell transplant within 14 days, or a solid organ transplant within 7 days before/after the study start
- You must be receiving care at one of the participating study hospitals
- A parent/guardian can sign consent, and the child can agree (assent) if appropriate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at the immune system in people who have received or are waiting for an organ transplant. It will help researchers better understand how to care for transplant patients by taking blood and tissue samples.
This trial tests whether giving special immune cells (called cytotoxic T lymphocytes) can fight viruses like CMV, adenovirus, EBV, or BK virus that are not responding to usual treatments. It is for people aged 0 to 29 with weakened immune systems due to inherited conditions or previous transplants.
This trial tests a treatment using specially trained immune cells (virus-specific T-cells) to fight stubborn infections with adenovirus, CMV, or EBV in people with weakened immune systems, such as after a stem cell or organ transplant.
This trial tests giving special immune cells to patients who had a stem cell transplant and are at high risk for viral infections. The cells may help prevent or fight infections like CMV and EBV after transplant.
This trial studies whether it’s safe and effective for HIV-positive people to receive organ transplants from HIV-positive donors. It focuses on matching HIV treatment before and after transplant and checking for major complications.
This trial tests a treatment using specially grown T-cells (a type of immune cell) to fight certain viruses that won't go away with standard medicines. It is for people who have had a stem cell or organ transplant, or who have a weak immune system, and who are struggling with adenovirus, CMV, or EBV infections.
Hear when a new Hematopoietic Cell Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.